Pfizer continues its buying spree

This just in:
Pfizer Inc. (NYSE:PFE) and King Pharmaceuticals, Inc. (ETR:KIG) recently issued a joint statement confirming that a merger agreement had been approved by the boards of both companies, and that through this agreement, Pfizer Inc. would acquire King Pharmaceuticals, Inc. for a sum of $3.6 billion. You can read the full article here.
Apparently Pfizer is very excited about not only King's pain drug portfolio, but its pipeline as well.